Arterial Spin-Labeling Perfusion for PHACE Syndrome

References

1. 1.↵
   1. Siegel DH,
   2. Tefft KA,
   3. Kelly T, et al

   . Stroke in children with posterior fossa brain malformations, hemangiomas, arterial anomalies, coarctation of the aorta and cardiac defects, and eye abnormalities (PHACE) syndrome: a systematic review of the literature. Stroke 2012;43:1672–74 doi:10.1161/STROKEAHA.112.650952 pmid:22442177

   Abstract/FREE Full Text
2. 2.
   1. Drolet BA,
   2. Dohil M,
   3. Golomb MR, et al

   . Early stroke and cerebral vasculopathy in children with facial hemangiomas and PHACE association. Pediatrics 2006;117:959–64 doi:10.1542/peds.2005-1683 pmid:16510684

   Abstract/FREE Full Text
3. 3.↵
   1. Hess CP,
   2. Fullerton HJ,
   3. Metry DW, et al

   . Cervical and intracranial arterial anomalies in 70 patients with PHACE syndrome. AJNR Am J Neuroradiol 2010;31:1980–86 doi:10.3174/ajnr.A2206 pmid:20705698

   Abstract/FREE Full Text
4. 4.
   1. Heyer GL,
   2. Millar WS,
   3. Ghatan S, et al

   . The neurologic aspects of PHACE: case report and review of the literature. Pediatr Neurol 2006;35:419–24 doi:10.1016/j.pediatrneurol.2006.06.021 pmid:17138012

   CrossRefPubMedWeb of Science
5. 5.↵
   1. Jack AS,
   2. Chow MM,
   3. Fiorillo L, et al

   . Bilateral pial synangiosis in a child with PHACE syndrome. J Neurosurg Pediatr 2016;17:70–75 doi:10.3171/2015.5.PEDS1578 pmid:26405843

   CrossRefPubMed
6. 6.↵
   1. Jernigan S,
   2. Storey A,
   3. Hammer C, et al

   . Moyamoya syndrome and PHACE syndrome: clinical and radiographic characterization of the intracranial arteriopathy and response to surgical revascularization. J Neurosurg Pediatr 2019;23:493–97 doi:10.3171/2018.10.PEDS18582 pmid:30717056

   CrossRefPubMed
7. 7.↵
   1. Metry DW,
   2. Garzon MC,
   3. Drolet BA, et al

   . PHACE syndrome: current knowledge, future directions. Pediatr Dermatol 2009;26:381–98 doi:10.1111/j.1525-1470.2009.00944.x pmid:19689512

   CrossRefPubMedWeb of Science
8. 8.↵
   1. Haggstrom AN,
   2. Garzon MC,
   3. Baselga E, et al

   . Risk for PHACE syndrome in infants with large facial hemangiomas. Pediatrics 2010;126:e418–26 doi:10.1542/peds.2009-3166 pmid:20643720

   Abstract/FREE Full Text
9. 9.↵
   1. Garzon MC,
   2. Epstein LG,
   3. Heyer GL, et al

   . PHACE syndrome: consensus-derived diagnosis and care recommendations. J Pediatr 2016;178:24–33.e22 doi:10.1016/j.jpeds.2016.07.054 pmid:27659028

   CrossRefPubMed
10. 10.↵
    1. Haller S,
    2. Zaharchuk G,
    3. Thomas DL, et al

    . Arterial spin labeling perfusion of the brain: emerging clinical applications. Radiology 2016;281:337–56 doi:10.1148/radiol.2016150789 pmid:27755938

    CrossRefPubMed
11. 11.↵
    1. Lee S,
    2. Yun TJ,
    3. Yoo RE, et al

    . Monitoring cerebral perfusion changes after revascularization in patients with Moyamoya disease by using arterial spin-labeling MR imaging. Radiology 2018;288:565–72 doi:10.1148/radiol.2018170509 pmid:29714677

    CrossRefPubMed
12. 12.↵
    1. Mamlouk MD,
    2. Hess CP

    . Arterial spin-labeled perfusion for vascular anomalies in the pediatric head and neck. Clin Imaging 2016;40:1040–46 doi:10.1016/j.clinimag.2016.06.009 pmid:27372212

    CrossRefPubMed
13. 13.↵
    1. Mamlouk MD,
    2. Nicholson AD,
    3. Cooke DL, et al

    . Tips and tricks to optimize MRI protocols for cutaneous vascular anomalies. Clin Imaging 2017;45:71–80 doi:10.1016/j.clinimag.2017.05.019 pmid:28622551

    CrossRefPubMed
14. 14.↵
    1. Boulouis G,
    2. Dangouloff-Ros V,
    3. Boccara O, et al

    . Arterial spin-labeling to discriminate pediatric cervicofacial soft-tissue vascular anomalies. AJNR Am J Neuroradiol 2017;38:633–38 doi:10.3174/ajnr.A5065 pmid:28104640

    Abstract/FREE Full Text
15. 15.↵
    1. Wright JN,
    2. Wycoco V

    . Asymmetric Meckel cave enlargement: a potential marker of PHACES syndrome. AJNR Am J Neuroradiol 2017;38:1223–27 doi:10.3174/ajnr.A5140 pmid:28408631

    Abstract/FREE Full Text
16. 16.↵
    1. Krowchuk DP,
    2. Frieden IJ,
    3. Mancini AJ, et al

    ; Subcommittee on The Management of Infantile Hemangiomas. Clinical practice guideline for the management of infantile hemangiomas. Pediatrics 2019;143:e20183475 doi:10.1542/peds.2018-3475 pmid:30584062

    Abstract/FREE Full Text
17. 17.↵
    1. Léaute-Labrèze C,
    2. Boccara O,
    3. Degrugillier-Chopinet C, et al

    . Safety of oral propranolol for the treatment of infantile hemangioma: a systematic review. Pediatrics 2016;138:e20160353 doi:10.1542/peds.2016-0353 pmid:27688361

    Abstract/FREE Full Text
18. 18.↵
    1. Olsen GM,
    2. Hansen LM,
    3. Stefanko NS, et al

    . Evaluating the safety of oral propranolol therapy in patients with PHACE syndrome. JAMA Dermatol 2020;156:186–90 doi:10.1001/jamadermatol.2019.3839 pmid:31825455

    CrossRefPubMed
19. 19.↵
    1. Holland KE,
    2. Frieden IJ,
    3. Frommelt PC, et al

    . Hypoglycemia in children taking propranolol for the treatment of infantile hemangioma. Arch Dermatol 2010;146:775–78 doi:10.1001/archdermatol.2010.158 pmid:20644039

    CrossRefPubMedWeb of Science
20. 20.↵
    1. Siegel DH

    . PHACE syndrome: infantile hemangiomas associated with multiple congenital anomalies—clues to the cause. Am J Med Genet C Semin Med Genet 2018;178:407–13 doi:10.1002/ajmg.c.31659 pmid:30580483

    CrossRefPubMed
21. 21.↵
    1. Mitchell S,
    2. Siegel DH,
    3. Shieh JT, et al

    . Candidate locus analysis for PHACE syndrome. Am J Med Genet A 2012;158a:1363–67 doi:10.1002/ajmg.a.35341 pmid:22544659

    CrossRefPubMed
22. 22.↵
    1. Mamlouk MD,
    2. Zimmerman B,
    3. Mathes EF, et al

    . Hearing loss in PHACE syndrome: clinical and radiologic findings. Childs Nerv Syst 2018;34:1717–24 doi:10.1007/s00381-018-3822-x pmid:29748705

    CrossRefPubMed
23. 23.↵
    1. Bolar DS,
    2. Gagoski B,
    3. Orbach DB, et al

    . Comparison of CBF measured with combined velocity-selective arterial spin-labeling and pulsed arterial spin-labeling to blood flow patterns assessed by conventional angiography in pediatric Moyamoya. AJNR Am J Neuroradioly 2019;40:1842–49 doi:10.3174/ajnr.A6262 pmid:31694821

    CrossRefPubMed
24. 24.↵
    1. Alsop DC,
    2. Detre JA,
    3. Golay X, et al

    . Recommended implementation of arterial spin-labeled perfusion MRI for clinical applications: a consensus of the ISMRM perfusion study group and the European consortium for ASL in dementia. Magn Reson Med 2015;73:102–16 doi:10.1002/mrm.25197 pmid:24715426

    CrossRefPubMed